HomeCompaniesProfile

64x Bio

Enabling next generation medicines. A comprehensive platform and… 


Company Size

11 - 50 employees

Year Founded

2017


About 64x Bio

The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up.

Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out.

Founders & Key People

Alexis Rovner

Alexis Rovner

Co-founder of 64x Bio

Share This Profile

More Companies

C.RIOUSLY

Seriously just cut-the-crap cereals

Atom and Coconut Pte Ltd

We help Professionals to manage their Business!

Version Story

GitHub for lawyers

Response

Control indirect spend from end-to-end.

ERC Equipoise Pte Ltd

ERCE is an independent energy consulting group, finding solutions and adding value for our clients.

Milo

The Family AI - a copilot for parents to tackle the invisible load of…

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.